S. Lenk

发表

MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results.

D. Beyersdorff, A. Winkel, B. Hamm, 2005, Radiology.

TP 53 Gene Mutations in Prostate Cancer Progression

S. Lenk, S. Loening, H. Schlechte, 2010 .

TP53 gene mutations in prostate cancer progression.

S. Lenk, S. Loening, H. Schlechte, 2010, Anticancer research.

Original article Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer

S. Lenk, S. Loening, H. Schlechte, 2008 .

Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer.

S. Lenk, S. Loening, H. Schlechte, 2008, Urologic oncology.

Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.

S. Lenk, S. Loening, H. Schlechte, 2005, Anticancer research.

Mutations of tumour suppressor gene P 53 ( TP 53 ) in tumour tissue and cellular urine sediments in urinary bladder cancer

S. Lenk, H. Schlechte, T. Ecke, 2005 .

p53 Tumour Suppressor Gene Mutations in Benign Prostatic Hyperplasia and Prostate Cancer

S. Lenk, S. Loening, D. Schnorr, 1998, European Urology.

Infektiologie

S. Lenk, B. Liedl, H. Schiefer, 2006, Facharztwissen Urologie.

Testosteronsubstitution in der Praxis

S. Lenk, D. Fahlenkamp, 2001 .

Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase in infertile men compared with a normal population.

S. Lenk, S. Loening, K. Jung, 2000, Human reproduction.

Worry, desire, and sexual satisfaction and their association with severity of ED and age.

S. Lenk, N. Knoll, O. Gralla, 2008, The journal of sexual medicine.

Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the ‘Cottbus Survey’ with 10 000 men

S. Lenk, N. Knoll, O. Gralla, 2007, BJU international.

Sildenafil response is influenced by the G protein beta 3 subunit GNB3 C825T polymorphism: a pilot study.

S. Lenk, U. Wetterauer, A. Eisenhardt, 2003, The Journal of urology.

Tissue inhibitors of metalloproteinases 1 and 2 in human seminal plasma and their association with spermatozoa.

S. Lenk, S. Loening, K. Jung, 2002, International journal of andrology.

Texture examinations on grain and thin section preparations of calcium oxalate calculi and their relations to pathogenetic parameters

S. Lenk, R. Koch, G. Schubert, 2004, Urological Research.

On the therapy of urolithiasis in chronic renal failure

S. Lenk, P. Althaus, W. Dutz, 2005, International Urology and Nephrology.

Urolithiasis associated with urogenital tuberculosis

S. Lenk, H. Oesterwitz, G. Schubert, 2004, Urological Research.

EAU guidelines for the management of genitourinary tuberculosis.

S. Lenk, K. Naber, H. Botto, 2005, European urology.

EAUGuidelines for theManagement of Genitourinary Tuberculosis

S. Lenk, K. Naber, H. Botto, 2005 .

Genitourinary tuberculosis

S. Lenk, J. Schroeder, 2001, Current opinion in urology.

European Association of Urology GUIDELINES ON URINARY AND MALE GENITAL TRACT INFECTIONS

S. Lenk, F. Selvaggi, A. Heidenreich, 2001 .

TP53 gene mutations as an independent marker for urinary bladder cancer progression.

S. Lenk, S. Loening, H. Schlechte, 2008, International journal of molecular medicine.

Quantitative differences in matrix metalloproteinase (MMP)-2, but not in MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 or TIMP-2, in seminal plasma of normozoospermic and azoospermic patients.

S. Lenk, S. Loening, K. Jung, 2002, Human reproduction.

Penile deviation--our therapeutic concept.

S. Lenk, B. Schönberger, 1994, Acta chirurgica Hungarica.

RANDOMIZED PROSEPECTIVE PLACEBO-CONROLLED THERAPY OF PEYRONIE'S DISEASE (IPP) WITH POTABAR (AMINOBENZOATE POTASSIUM)

S. Lenk, U. Rebmann, W. Aulitzky, 1999 .

Renal autotransplantation for idiopathic retroperitoneal fibrosis

S. Lenk, P. Althaus, H. Oesterwitz, 1994, International Urology and Nephrology.

[Obstructive disorders of urine transport of the upper urinary tract--benign and malignant retroperitoneal fibrosis].

S. Lenk, H. Oesterwitz, G. Stobbe, 1990, Zeitschrift fur Urologie und Nephrologie.

Late complication of Boari bladder flap

D. Beyersdorff, S. Lenk, L. Kopka, 2003, European Radiology.

Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments.

S. Lenk, S. Loening, H. Schlechte, 2000, Cancer detection and prevention.

[Corpus cavernosum injection treatment of erectile impotence].

S. Lenk, G. Schönherr, I. Korner, 1990, Zeitschrift fur Urologie und Nephrologie.

[Genitourinary tuberculosis in Germany: diagnosis and treatment].

S. Lenk, 2011, Der Urologe. Ausg. A.

Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging.

Bernd Hamm, Matthias Taupitz, Dirk Beyersdorff, 2002, Radiology.

TP53 mutation in prostate needle biopsies--comparison with patients follow-up.

S. Lenk, K. Miller, H. Schlechte, 2007, Anticancer research.

Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests compared.

S. Lenk, S. Loening, K. Jung, 1999, Urology.

Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.

S. Lenk, S. Loening, C. Stephan, 2007, Anticancer research.

Acute partial segmental thrombosis of the corpus cavernosum: imaging findings on ultrasound, computed tomography, and magnetic resonance imaging.

S. Lenk, S. Loening, P. Asbach, 2008, Clinical imaging.

Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging.

D. Beyersdorff, B. Hamm, S. Lenk, 2002, Radiology.